Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:53 AM
Ignite Modification Date:
2025-12-24 @ 11:53 AM
NCT ID:
NCT07212361
Eligibility Criteria:
Inclusion Criteria:
* Healthy mother and healthy pregnancy
* Singleton pregnancy,
* Mothers who speak Finnish or Swedish
* Mothers who are planning to breastfeed or give breastmilk by bottle to the infant
* Infants who are expected to be healthy and who will not require BCG vaccination.
Exclusion Criteria:
* Participants who lives further than a 2-hour drive from Meilahti, Helsinki, Finland
* Mothers who are not planning to breastfeed or feed breastmilk by bottle to the infant
* Mothers who are diagnosed with gestational diabetes, pre-eclampsia or who have been receiving antibiotics during the pregnancy or delivery
* Premature infants born before the pregnancy week 37
* Infants, who are born by urgent cesarean section or emergency cesarean section
* Infants, who receive antibiotics during the first week of life
* Infants, who are diagnosed with a disease, congenital anomaly or who receive less than 9 Apgar points at 5 minutes.
* Infants, who receive BCG-vaccine
Healthy Volunteers:
True
Sex:
ALL
Maximum Age:
50 Years
Study:
NCT07212361
Study Brief:
Protocol Section:
NCT07212361